DEF 14A: Microvast Holdings Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals

Microvast Holdings will hold its 2024 Annual Meeting of Stockholders virtually on October 18, 2024, to vote on the election of directors and ratification of the company's independent accounting firm.

Summary

• Microvast Holdings, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on October 18, 2024, at 9:00 a.m. Central Time.
• Stockholders will vote on the election of three Class III director nominees and the ratification of Deloitte Touche Tohmatsu Certified Public Accountants LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
• The Board recommends voting FOR the election of the director nominees and FOR the ratification of Deloitte's appointment.
• The record date for determining stockholders eligible to vote is August 21, 2024.
• The company is providing access to proxy materials over the Internet, with a Notice of Internet Availability of Proxy Materials being mailed on or about September 6, 2024.
• As of the record date, there were 316,887,855 shares of common stock issued and outstanding.
• The company's common stock and warrants currently trade on the Nasdaq Global Select Market under the ticker symbols MVST and MVSTW, respectively.
• Microvast received a notice from Nasdaq on March 26, 2024, that its average closing bid price was below $1 per share, requiring the company to regain compliance within 180 days.
• Yeelong Tan Balladon and Yanzhuan Zheng will resign from the Board effective as of the date of the 2024 Annual Meeting.
• The Board has nominated Isida Tushe and Yixin Pan for election at the 2024 Annual Meeting.
• Audit fees for 2023 were $1.8 million, up from $1.6 million in 2022.
• Tax fees for 2023 were $0.1 million.
• The company is an emerging growth company and has elected to comply with certain reduced public company reporting requirements.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily providing factual information about the upcoming annual meeting and related proposals. The Nasdaq compliance issue introduces a slightly negative element, but the overall sentiment is balanced.

Positives

• The Board is actively engaged in corporate governance, as evidenced by the establishment of key committees and the adoption of corporate governance guidelines.
• The company is providing stockholders with convenient access to proxy materials via the internet.
• The company has procedures in place for stockholders to communicate with the Board.
• The Audit Committee is composed of independent directors who are financially literate, with Arthur Wong serving as the financial expert.
• The company has adopted a code of ethics applicable to its directors, officers, and employees.

Negatives

• Microvast received a notice from Nasdaq that its average closing bid price was below $1 per share, requiring the company to regain compliance within 180 days.
• The company has two vacant director positions.
• The company has had recent resignations from the Board.
• The company is an emerging growth company and has elected to comply with certain reduced public company reporting requirements, which means less disclosure about executive compensation.

Risks

• The company's securities have an added indicator on NASDAQ.com indicating that it is non-compliant.
• If the PCAOB determines in the future that it no longer has full access to inspect and investigate completely accounting firms in mainland China and Hong Kong and we use an accounting firm headquartered in one of these jurisdictions to issue an audit report on our financial statements filed with the SEC, we would be identified as a Commission-Identified Issuer following the filing of the annual report on Form 10-K for the relevant fiscal year.
• In accordance with the HFCAA, our securities would be prohibited from being traded on a national securities exchange or in the over-the-counter trading market in the United States if we are identified as a Commission-Identified Issuer for two consecutive years in the future.
• A prohibition of being able to trade in the United States would substantially impair your ability to sell or purchase our securities when you wish to do so, and the risk and uncertainty associated with delisting would have a negative impact on the price of our securities.
• Also, such a prohibition would significantly affect our ability to raise capital on terms acceptable to us, or at all, which would have a material adverse impact on our business, financial condition and prospects.

Future Outlook

The company is exploring available options to regain compliance with the Nasdaq minimum closing bid price rule.

Management Comments

• Yang Wu, Chairman and Chief Executive Officer, encourages stockholders to read the Proxy Statement and submit their vote as soon as possible.

Industry Context

The document does not provide specific industry context beyond the general information related to publicly traded companies and corporate governance.

Management Changes

Related Party Transactions

• Mr. Zheng receives a consulting fee equal to $25,000 per month, which Mr. Zheng voluntarily reduced to $16,667 per month effective March 11, 2024.
• The Stockholders Agreement provides that any increase or decrease in the number of directors will require the affirmative vote of the Wu Directors.

Stakeholder Impact

• Stockholders are encouraged to vote on the proposals, which will impact the composition of the Board and the selection of the company's auditor.
• The Nasdaq compliance issue could impact the value of the company's stock and the ability of stockholders to trade the stock.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the 2024 Annual Meeting of Stockholders on October 18, 2024.
• The company must regain compliance with Nasdaq's minimum bid price requirement.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Board of Directors, Director Election, Deloitte, Auditor Ratification, Corporate Governance, Nasdaq, Microvast